{
    "clinical_study": {
        "@rank": "80432", 
        "acronym": "EVIDENCE", 
        "arm_group": [
            {
                "arm_group_label": "Treament", 
                "arm_group_type": "Experimental", 
                "description": "Intervention Vitamin D2"
            }, 
            {
                "arm_group_label": "Control", 
                "arm_group_type": "No Intervention", 
                "description": "Not take Vitamin D2"
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators hypothesize that the chronic kidney disease patients who suffer from\n      vitamin D deficiency will be benefit from given Vitamin D2 because coronary artery\n      calcification and hyperparathyroidism will be improved."
        }, 
        "brief_title": "Effect of Vitamin D Supplementation on Coronary Calcification and Parathyroid Hormone in CKD Patients", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Chronic Kidney Disease", 
            "Vitamin D Deficiency"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Calcinosis", 
                "Kidney Diseases", 
                "Vitamin D Deficiency", 
                "Renal Insufficiency, Chronic", 
                "Kidney Failure, Chronic"
            ]
        }, 
        "detailed_description": {
            "textblock": "We will call for 350 CKD patients (250 CKD3-5stage and 100 CKD5D stage)who suffer from\n      vitamin D deficiency.They will be divided into 2 groups. One group will be given vitamin D\n      and the other will not. They will take coronary artery CT test every year(in 2 years).We\n      will compare the coronary calcification progression between  the 2 groups."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  chronic kidney disease patients (3-5D)\n\n          -  serum 25\uff08OH\uff09D < 40nmol/L(16ng/ml)\uff0cserum calcium < 2.55mmol/L\uff0810.2mg/dL\uff09\uff1b\n\n          -  willing to sign\n\n          -  could obey the follow up design\n\n        Exclusion Criteria:\n\n          -  allergy to vitamin D\n\n          -  heart failure (NYHA more than 2 grade)\n\n          -  pregnant\n\n          -  malignant tumor\n\n          -  critical hepatic disease\n\n          -  taking Vitamin D or analogue in 3 recent months\n\n          -  taking other clinical trial"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "350", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 21, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01672047", 
            "org_study_id": "PURCP201103"
        }, 
        "intervention": {
            "arm_group_label": "Treament", 
            "description": "25\uff08OH\uff09D level <12 nmol/L                50000IU/weekX12week\uff0c 12-39 nmol/L                50000IU/weekX4week then\uff0c50000IU/month\uff0c 40-75 nmol/L                50000IU/month\uff0c 75-116.75nmol/L          25000IU/month\uff0c\n\uff1e116.75nmol/L          stopped.", 
            "intervention_name": "Vitamin D2", 
            "intervention_type": "Drug", 
            "other_name": "Vitmain D2 capsule"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Vitamin D", 
                "Ergocalciferols", 
                "Vitamins", 
                "Hormones"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "The 25(OH) vitamin D level", 
            "The 1.25(OH) vitamin D level", 
            "The intact PTH level", 
            "The calcification score of coronary artery", 
            "The microalbuminuria level"
        ], 
        "lastchanged_date": "August 29, 2012", 
        "location": {
            "contact": {
                "email": "suizhun@bjmu.edu.cn", 
                "last_name": "Sui Zhun, MD", 
                "phone": "86-010-88325507"
            }, 
            "contact_backup": {
                "email": "wangmei@163.com", 
                "last_name": "Wang Mei, MD", 
                "phone": "86-010-88325513"
            }, 
            "facility": {
                "address": {
                    "city": "Beijing", 
                    "country": "China", 
                    "state": "Beijing", 
                    "zip": "100044"
                }, 
                "name": "The People's Hospital of Peking University"
            }, 
            "investigator": {
                "last_name": "Wang Mei, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effect of Vitamin D Supplementation on Coronary Calcification and Parathyroid Hormone in CKD Patients", 
        "overall_official": {
            "affiliation": "Peking University People's Hospital", 
            "last_name": "Mei Wang, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "We use CT to detect the coronary artery calcification score in the chronic kidney disease patients for 3 times (baseline, 12 month and 24 month). We will compare the 2 arms \uff08treatment or not\uff09to know if there is any difference\u3002", 
            "measure": "the improvement of coronary artery calcification", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01672047"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Peking University People's Hospital", 
            "investigator_full_name": "Wang Mei", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "We detect the microalbuminuria in the chronic kidney disease patients for 5 times (baseline, 6 month,12 month 18month and 24 month). We will compare the 2 arms \uff08treatment or not\uff09to know if there is any difference\u3002", 
            "measure": "the improvement of proteinuria", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "source": "Peking University People's Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Peking University People's Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2012"
    }
}